Browsing “Patient AccessPatient Access | EVERSANA”

ICER’s Alternative Pricing Models: New Threats to Biopharmaceutical’s Profitability and Innovation

The Institute for Clinical and Economic Review (ICER) has been very responsive to the current public health pandemic, from adjusting their review timelines to assessing COVID-19 impact on drug pricing and patient access. Within a few days of Gilead’s remdesivir gaining emergency approval by the U.S. Food and Drug Administration (FDA), ICER has published an analysis on […]

COVID-19’s Impact on Brand Access

The current public health pandemic is impacting healthcare stakeholders from doctors and nurses in the frontlines to payers and PBMs. EVERSANA™ is monitoring the constant changes to access and benefit consideration, tracking payer responses, and key trends that may impact your brand access strategy. According to recent research released by Health Strategies Insights by EVERSANA™, […]

Brand Access Marketplace Dynamics: Respiratory

This summary provides highlights from robust longitudinal insights reports released throughout the year and available at our INTELLICENTER® portal. The Brand Access Marketplace Dynamics reports identify current and future access landscapes providing insights to support effective identification of opportunities and risks for Respiratory brands. Get answers to key questions such as: What level of influence […]

Brand Access Marketplace Dynamics: Multiple Sclerosis

This summary provides highlights from robust longitudinal insights reports released throughout the year and available at our INTELLICENTER® portal. The Brand Access Marketplace Dynamics reports identify current and future access landscapes providing insights to support effective identification of opportunities and risks for Multiple Sclerosis brands. Get answers to key questions such as: What level of […]

Brand Access Marketplace Dynamics: HIV

This summary provides highlights from robust longitudinal insights reports released throughout the year and available at our INTELLICENTER® portal. The Brand Access Marketplace Dynamics reports identify current and future access landscapes providing insights to support effective identification of opportunities and risks for HIV brands. Get answers to key questions such as: What level of influence […]

Brand Access Marketplace Dynamics: Autoimmune

This summary provides highlights from robust longitudinal insights reports released throughout the year and available at our INTELLICENTER® portal. The Brand Access Marketplace Dynamics reports identify current and future access landscapes providing insights to support effective identification of opportunities and risks for Autoimmune brands. Get answers to key questions such as: What level of influence […]

The 2020 Playbook Addendum: Augment Your Frontline to Boost Sales Momentum

In the midst of a global pandemic, the role of commercial field teams evolved right before our eyes. Digital sales aids and tele-detailing are now mandatory sales tactics in a virtual Provider-Rep engagement. Now that field teams are starting to settle into “the new normal,” manufacturers are turning their attention to the next phase: make […]

Proactive Steps to Ensure Appropriate Utilization of the First Disease-Modifying Therapy for Alzheimer Disease

Widespread hope exists that aducanumab will soon gain Food and Drug Administration approval as the first disease-modifying therapy for patients with mild cognitive impairment associated with Alzheimer disease (AD), which could significantly impact the management of AD. If approved, challenges need to be addressed to properly identify patients who will benefit from treatment and ensure […]

Two Key Questions About Payer Strategies in 2020

In a PM360 Focus on Payer Strategies feature, Brian Davis addresses the question: Besides efforts to lower drug prices and increase transparency, what market access challenges/barriers will cause pharma companies the most stress this year? How can companies overcome this challenge/barrier? In his response, Brian highlights a few of the 2020 challenges to market access, […]

ACCESSEXPRESS® by EVERSANA Payer Coverage and Reimbursement Case Study

ACCESSEXPRESS allows you to have full control of the survey process getting answers to your most pressing business questions within hours. See how our client used our research platform to assess payer coverage and reimbursement for an upcoming indication expansion. Learn more about ACCESSEXPRESS® by EVERSANA! Fill out the form below to download the Case […]